Processa Pharmaceuticals financial statements
프로세사 파머슈티컬스NASDAQ:PCSA · Nasdaq · Healthcare · sector #13$1.49-7.45%
2026-10-05 closeProcessa Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$12M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy